500,000 eligible to benefit from new non-hormonal treatment for hot flushes caused by menopause
A new treatment option for menopausal hot flushes and night sweats can be used in the NHS when hormone replacement therapy (HRT) is not suitable.
News, blogs and podcasts
Latest articles
NICE publishes first quality standard to improve care for people with rare diseases
Ahead of Rare Disease Day on 28 February, we've published our first ever quality standard on rare diseases, and the first to have been developed in partnership with an external organisation.
More than 20,000 people benefitting from innovative migraine pills recommended by NICE
A new type of tablet specifically designed to prevent migraine is transforming lives across England, with the number of people being prescribed these medicines more than tripling in just one year.
First treatment for vitiligo recommended by NICE for NHS use, bringing hope to over 80,000 people
For the first time, NICE has recommended a medicine that effectively treats the underlying cause of devastating skin condition vitiligo
Latest in-depth
From surviving to thriving
Hear from Ammaarah as she explains the remarkable impact hybrid closed loop technology has had on her life and how its successful rollout is the model we want to replicate.
How biosimilars and generics can deliver better value for the NHS
Read our explainer on biosimilars and generics and the potential benefits they can offer.
Latest blogs
Saving babies' hearing: how a world-first rapid genetic test is transforming neonatal care
Learn how NICE's healthtech guidance helped bring life-changing genetic testing to neonatal units across the UK, saving 20 babies' hearing so far with potential to prevent hearing loss in 200 babies annually.
Driving biosimilar adoption through collaboration
How a collaborative taskforce is helping increase the uptake of biosimilars within the health and care sector.
Latest podcasts
How NICE guidance is accelerating access to innovative migraine treatments
The asthma guideline – one year on
